The global biosurgery market size is projected to reach USD 20.1 billion by the year 2026, advancing at a CAGR of 7.1% during the forecast period. Biosurgery products find application in surgical procedures for the purpose of adhesion or wound sealing, as well as healing damaged tissues and bones. A basic treatment principle is the use of maggots or larvae for preventing infection of wounds or delayed healing. Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcers, malignant wounds, and infected surgical wounds.
Factors such as the availability of multifunctional products in the industry and the increasing number of surgeries due to the growing prevalence of lifestyle-related diseases and sports-related injuries are projected to drive the growth. Additionally, increasing cases of blood clotting observed among patients prone to excessive blood loss has fast-tracked the need for efficient blood loss management methods, which is expected to drive the market growth. Furthermore, the growing prevalence of severe trauma injuries is another factor expected to aid market development over the coming years. As per the CDC, a blood clot is a cause of death for 100,000 people every year, which makes it imperative for medical facilities to establish innovative surgery techniques to prevent these fatalities.
The global biosurgery market has been broadly segmented on the basis of product and application. With regards to products, the market comprises surgical sealants, hemostatic agents, adhesion barriers, soft tissue attachments, and bone graft attachments, among others. On the basis of application, the market is classified into general surgery, cardiovascular surgery, orthopedic surgery, and neurological surgery, among others. The major global industry players include Johnson & Johnson, Baxter, Medtronic, Pfizer, Sanofi, B. Braun Melsungen, Stryker, and Integra LifeSciences Corporation.
Biosurgery Market Report Highlights
·The increased prevalence of diabetes raises the risk of related infections and wounds, such as diabetic foot ulcers, with the American College of Physicians stating that the global annual incidence of the disorder was 6.3% in 2017. This has been projected to increase the demand for biosurgery globally.
·The continued growth in the geriatric population is expected to provide numerous growth opportunities to the industry. As per the WHO, the global population aged 60 years or more is expected to hit 2 billion, which is expected to intensify the requirement of surgical procedures over the coming years
·The current situation of the coronavirus pandemic across the globe has led to a drastic reduction in surgeon and physician visits for people suffering from chronic diseases. Biosurgery is expected to witness sharp industry growth in this period, as it reduces the number of patient visits and is economical, while also proving to be time-saving for healthcare professionals
·Based on product, the surgical sealant held the largest market share in 2018, on account of the growing prevalence of sports-related injuries, coupled with an increase in the number of surgeries performed globally
·In terms of application, the general surgery segment held the largest market share in 2018, while the cardiovascular surgery segment is expected to register the fastest CAGR through 2026. As per the WHO, CVDs accounted for 31% of the total global mortality in 2016 (17.6 million people), which projects as an avenue for market growth for biosurgery
·North America held the largest market share in 2018, owing to favorable reimbursement policies, local presence of key market players, and supportive government initiatives
·The market is characterized mainly by new product launches, and mergers and acquisitions by the major players. For example, in June 2019, Ethicon, a Johnson & Johnson subsidiary, announced FDA clearance for its Vistaseal applicators for utilization during open or laparoscopic surgical procedures
“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/biosurgery-market/request/rs1
Biosurgery Market Segmentation
Grand View Research has segmented the global biosurgery market report on the basis of product, application, and region:
Biosurgery Product Outlook (Revenue, USD Million, 2015 – 2026)
-
Surgical Sealants
-
Hemostatic Agents
-
Adhesion Barriers
-
Soft Tissue Attachments
-
Bone Graft Attachments
-
Others
Biosurgery Application Outlook (Revenue, USD Million, 2015 – 2026)
-
General Surgery
-
Orthopedic Surgery
-
Cardiovascular surgery
-
Neurological Surgery
-
Others
Biosurgery Regional Outlook (Revenue, USD Million, 2015 – 2026)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
U.K.
-
France
-
Italy
-
Spain
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Colombia
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
List of Key Players of Biosurgery Market
• Johnson & Johnson (Ethicon)
• Medtronic Plc
• Strykers
• Baxter International Inc.
• C.R. Bard
• Sanofi
• Pfizer
• B. Braun Melsungen AG
• Integra Lifesciences Corporation
Have Any Query? Ask Our Experts for More Details on Report: https://www.grandviewresearch.com/inquiry/6695/ibb
Browse Related Reports @
General Surgery Devices Market – https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across a multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/biosurgery-market